MAR 28, 2019 9:00 AM PDT

Analytical Variations: Old Problem - New Consequences

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • CEO, Certus Analytics, Founder, CannaSafe Analytics
    Biography
      Matt Haskin was the founder and previous CEO of CannaSafe Analytics, which, under his vision and leadership, became the first cannabis laboratory in the United States to be awarded an ISO 17025:2005 accreditation in 2012. He holds a Bachelor of Science degree from Columbia State University and has extensive experience in both domestic and international business. A chronic entrepreneur, Matt struck upon the concept of a medical cannabis laboratory in late 2009 after observing close family and friends struggle with concerns over the safety of the cannabis they used as medicine. With no industry established protocols or methods for testing cannabis, Matt set out to develop a lab that would set the standard and earn the trust of its clients. In February 2015 Matt was appointed Vice Chair of the Independent Laboratory Advisory Committee to the state of Nevada. The Committee makes policy recommendations on the state's cannabis program. Matt is also a member of the AOCS Cannabis Expert Panel, sits on the board of directors of the California Minority Alliance and is a member of the Green Standard Working Group. He was honored to be nominated and evaluated for the position of Bureau Chief of the California Bureau of Cannabis Control. Matt sold CannaSafe in October 2016 and now heads up Certus Analytics, a BCC licensed California cannabis compliance laboratory.

    Abstract

    Analytical variation, most commonly referred to as - varying lab results - can be both inter-lab as well as intra-lab. Lab results permeate virtually all segments of the industry, from B2B purchasing decisions to consumer confidence and brand building. It is not new, nor is it unique to cannabis, but that doesn’t make it any less frustrating or downright maddening to the business owners that are subjected to it. And to compound matters, heading into the second quarter of 2019, the economic consequences can be severe. 

    Learning Objectives: 

    1. We will learn about the Uncertainty of Measurement, the role it plays in analytical variation and how to minimize uncertainty. 
    2. Understanding how to improve the quality of the measurement. 
     


    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    OCT 22, 2020 8:00 AM PDT
    C.E. CREDITS
    OCT 22, 2020 8:00 AM PDT
    Abstract: Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR has a broad range of applications, includi...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    Loading Comments...
    Show Resources
    Attendees
    • See more